Pharmacokinetic and Pharmacodynamic Evaluation of the Novel CCR1 Antagonist CCX354 in Healthy Human Subjects: Implications for Selection of Clinical Dose
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacokinetic and Pharmacodynamic Evaluation of the Novel CCR1 Antagonist CCX354 in Healthy Human Subjects: Implications for Selection of Clinical Dose
Authors
Keywords
-
Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 89, Issue 5, Pages 726-734
Publisher
Springer Nature
Online
2011-03-30
DOI
10.1038/clpt.2011.33
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preclinical and clinical investigation of a CCR5 antagonist, AZD5672, in patients with rheumatoid arthritis receiving methotrexate
- (2010) Daniëlle M. Gerlag et al. ARTHRITIS AND RHEUMATISM
- Evaluation of the effect of the specific CCR1 antagonist CP-481715 on the clinical and cellular responses observed following epicutaneous nickel challenge in human subjects
- (2010) Jeanett Borregaard et al. CONTACT DERMATITIS
- CCR1 Antagonists: What Have We Learned From Clinical Trials
- (2010) Ronald P. Gladue et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Anti-chemokine small molecule drugs: a promising future?
- (2010) Amanda EI Proudfoot et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Characterization of CCX282-B, an Orally Bioavailable Antagonist of the CCR9 Chemokine Receptor, for Treatment of Inflammatory Bowel Disease
- (2010) M. J. Walters et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- FDA Review Summary: Mozobil in Combination with Granulocyte Colony-Stimulating Factor to Mobilize Hematopoietic Stem Cells to the Peripheral Blood for Collection and Subsequent Autologous Transplantation
- (2010) Michael Brave et al. ONCOLOGY
- Prevalence of specific types of arthritis and other rheumatic conditions in the ambulatory health care system in the United States, 2001-2005
- (2010) Jeffrey J. Sacks et al. ARTHRITIS CARE & RESEARCH
- Impact of digital ulcers on disability and health-related quality of life in systemic sclerosis
- (2009) L Mouthon et al. ANNALS OF THE RHEUMATIC DISEASES
- MLN3897 plus methotrexate in patients with rheumatoid arthritis: Safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double-blind, placebo-controlled, randomized, proof-of-concept study
- (2009) Clarissa E. Vergunst et al. ARTHRITIS AND RHEUMATISM
- CCR2 receptor blockade alters blood monocyte subpopulations but does not affect atherosclerotic lesions in apoE−/− mice
- (2009) Robert J. Aiello et al. ATHEROSCLEROSIS
- Chemokine receptor antagonists: part 2
- (2009) James E Pease et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Chemokine receptor antagonists: Part 1
- (2009) James E Pease et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Quantitative Prediction and Clinical Observation of a CYP3A Inhibitor-Based Drug-Drug Interactions with MLN3897, a Potent C-C Chemokine Receptor-1 Antagonist
- (2009) C. Lu et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Modulation of CCR2 in rheumatoid arthritis: A double‐blind, randomized, placebo‐controlled clinical trial
- (2008) Clarissa E. Vergunst et al. ARTHRITIS AND RHEUMATISM
- Scavenging roles of chemokine receptors: chemokine receptor deficiency is associated with increased levels of ligand in circulation and tissues
- (2008) A. E. Cardona et al. BLOOD
- Microbes in Gastrointestinal Health and Disease
- (2008) Andrew S. Neish GASTROENTEROLOGY
- Maraviroc for Previously Treated Patients with R5 HIV-1 Infection
- (2008) Roy M. Gulick et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chemokines and Their Receptors: Drug Targets in Immunity and Inflammation
- (2007) Antonella Viola et al. Annual Review of Pharmacology and Toxicology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started